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INTRODUCTION 
 
MicroRNAs (miRNAs) are small non-coding RNAs 
(20-22 nucleotides) that regulate gene expression by 
binding to their target messenger RNA (mRNA), thus 
resulting in the mRNA’s direct translational repression, 
RNA degradation or a combination of the two. MiRNAs 
have been shown to have a crucial role in regulating 
almost all cellular processes including cell growth, 
proliferation and differentiation [1, 2]. Mesenchymal 
stem/stromal cells (MSC) have been widely used in 
various clinical applications, taking advantage of their 
regenerative and immunomodulative properties [3]. Due 
to the recognized significance of miRNA regulation in 
organismal development and stem cell differentiation 
[4, 5], most studies investigating the role of miRNA 
regulation in MSCs have focused on the differentiation 
of MSCs. In addition to the regenerative potential of 
MSCs, it is actually the immunomodulative properties 
that make them an attractive candidate for therapeutic 
applications aiming for treatment of immune system 
disorders. MSCs are known to interact with many 
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ABSTRACT 
 
Mesenchymal stromal cells (MSC) are currently used in many cell based therapies. Prior to use in therapy, 
extensive expansion is required. We used microarray profiling to investigate expansion induced miRNA and 
mRNA expression changes of bone marrow MSCs (BM-MSCs) derived from old and young donors. The 
expression levels of 36 miRNAs were altered in cells derived from the old and respectively 39 miRNAs were 
altered in cells derived from young donors. Of these, only 12 were differentially expressed in both young and 
old donor BM-MSCs, and their predicted target mRNAs, were mainly linked to cell proliferation and senescence. 
Further qPCR verification showed that the expression of miR-1915-3p, miR-1207, miR-3665, and miR-762 
correlated with the expansion time at passage 8. Previously described BM-MSC-specific miRNA fingerprints 
were also detected but these remained unchanged during expansion. Interestingly, members of well-studied 
miR-17/92 cluster, involved in cell cycle regulation, aging and also development of immune system, were down-
regulated specifically in cells from old donors. The role of this cluster in MSC functionality is worth future 
studies since it links expansion, aging and immune system together. 
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immune system cells, thus modulating immunological 
responses both in vitro and in vivo [6]. Several miRNA 
molecules (including members of miR-17/92 cluster, 
miR-181 and miR-155) have been shown to be key 
regulators of various immune responses, such as T-cell 
development [7]. 
 
Mesenchymal stromal cells can be isolated from 
virtually any tissue [8]. In therapeutic applications, bone 
marrow (BM), adipose tissue (AT) and cord blood (CB) 
are the most relevant sources. Although the different 
origins have been shown to produce MSCs with 
different immunomodulatory properties [9], the results 
from various studies are contradictory [10]. Since 
miRNA regulation is thought to be one of the key 
players in MSC differentiation and functionality, it has 
been proposed that MSCs may have a typical miRNA 
expression pattern which varies only slightly according 
to the tissue origin [11]. 
 
The age of MSC donors and the required in vitro 
expansion of the therapeutic MSCs are considered to be 
factors that may affect the properties and functionality 
of MSCs and eventually have a negative effect on the 
therapeutic outcome [12, 13]. The age-dependent 
changes in miRNA expression may be one possible 
explanation for the observed differences between the 
old and younger donors. Although miRNA expression is 
relatively stable in the MSCs, some age-dependent 
changes in miRNA expression have been previously 
identified [14]. Interestingly, the miRNA expression of 
hBM-MSCs and hAT-MSCs is differently affected by 
the donor age [15]. Previous reports also indicate that 
the replicative senescence is at least partly driven by 
miRNA regulation [16, 17]. The results are, however, 
contradictory and the influence of the donor age on the 
senescence remains unclear. 
 
In this study, we investigated the age-related changes in 
miRNA regulation in human BM- MSCs by analyzing 
age-induced changes in miRNA expression profiles 
together with mRNA expression. We were able to show 
that, as opposed to mRNA expression levels, miRNA 
levels underwent only minor changes during continuous 
passaging. Interestingly, the age of the donor had even 
less effect on miRNA expression. Therefore, this study 
shows that miRNA expression is rather robust and BM-
MSCs have a distinct miRNA expression pattern that 
could provide new identifiers for MSCs.  
 
RESULTS 
 
MiRNA expression is changed during expansion 
 
MSCs were collected and characterized from five young 
adult donors (mean age 22.3) and four elderly donors 
(mean age 76) as previously described [13]. The 
miRNA expression profiles of BM-MSCs collected 
from three young adult donors and three old donors 
were analyzed using Agilent Human miRNA 8x60K 
microarray (release 16.0), which contains probes for 
1,205 human miRNA molecules, 294 of which were 
expressed in studied samples (Table S1). Let-7a, let 7b, 
let 7c, let-7e, let-7f, let 7i, miR-100, miR-125b, miR-
199 ad miR-21 were the 10 most highly expressed 
miRNAs in all the samples studied, and all of them are 
included in the distinct miRNA signature of MSCs [18]. 
 
From among the 308 miRNAs, we were able to identify 
63 differentially expressed miRNAs (Fig. 1). 
Interestingly, the miRNA profiles of the young and 
elderly donors were relatively similar in the early 
passages. The most prominent changes in miRNA 
expression were seen towards the late passages. During 
the expansion of BM-MSCs derived from young 
donors, the expression of 39 miRNAs was changed, 
whereas 36 miRNAs were differently expressed in old 
donors. BM-MSCs from young donors behaved 
differently during passaging compared to BM-MSCs 
from the old donors, as both groups shared only 12 
differentially regulated miRNAs (Fig. 1). The direction 
of expression change was also opposite. Our results 
demonstrate predominant down-regulation of miRNA 
expression in the old donors’ samples and up-regulation 
in samples from young donors. Of the twelve miRNAs 
that underwent changes in their expression during 
expansion in both donor groups, ten were up-regulated 
and two were down-regulated in both young and old 
donors.  
 
In order to validate the microarray results, we 
performed quantitative PCR for a selected set of 
differently expressed miRNAs in both young and old 
donor BM-MSCs (miR-1207, miR-1915-3p, miR-3665, 
miR4281, and miR-762). Our qPCR results confirmed 
our microarray results. When individual donors were 
analyzed separately, we noticed that BM-MSCs from 
donors 081 (young) and 271 (old) showed no 
considerable changes during passaging (Fig. 2). These 
two donors were excluded from further pairwise 
analyses (Table 1). 
 
To investigate whether the up-regulation of miRNA 
expression is a continuous process we analyzed 
passages 4, 6, and 8 by qPCR (Fig. 2). We found that 
miRNA expression increases already at passage 6, but 
the most dramatic changes were seen from passage 6 to 
8. This indicates that the original selection of passage 8 
for miRNA microarray analysis, made on the basis of 
previous findings on proliferation rate, morphology, 
lipid profile, and gene expression changes, was justified 
[13]. 
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Table 1. Validation of microarray results with qPCR.  
 o8-o4 y8-y4 
qRT-PCR microarray qRT-PCR microarray 
miRNA FC p FC p FC p FC p 
miR-762 3.62 0.04 2.83 0.04 2.83 0.04 3.35 0.05 
miR-3665 3.41 0.03 2.31 0.04 2.31 0.04 2.02 0.05 
miR-1915-3p 2.13 0.01 2.26 0.04 2.26 0.04 2.68 0.05 
miR-4281 2.05 0.06 1.67 0.05 1.67 0.05 2.09 0.06 
miR-1207-5p 1.17 0.09 2.08 0.03 2.08 0.03 1.18 0.07 
MSC donors 081 and 271 were removed from calculation 
  
Figure 1. Differentially expressed miRNAs in BM-MSCs. Microarray analysis of young and old donors’ MSCs found 12 
miRNAs whose expression was changed in young and old donors. Fold changes are presented as a heatmap where green color 
indicates up-regulation and red color indicates down-regulation of the microRNA. 
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MiRNA expression correlates with expansion time 
 
In our previous work, we have shown that the 
proliferation capacity and the actual time until passage 8 
is reached vary greatly between individual BM-MSC 
donors [13]. Similar variation was seen in qPCR with 
delta Ct values between donors at passage 8 (Fig. 3A). 
To investigate whether the variation in miRNA 
expression could be explained by expansion time, we 
performed a correlation analysis. When both young and 
old donor BM-MSCs were included in the analysis, the 
dct values of miR-762, miR-1207, miR-1915 and miR-
3665 at passage 8 inversely correlated (P<0.05) with the 
expansion time, whereas for miR-4281, such correlation 
was only seen in the young donors. (Fig. 3B-F). 
 
Potential miRNA targets are found mostly in 
functional pathways of cellular growth, assembly 
and organization   
 
In order to elucidate the biological processes or 
pathways that are affected by the changed miRNA 
 
Figure 2. qPCR results of selected miRNAs in five young and four old BM-MSC donors. MiRNA expression at passages 4, 6 
and 8 was analyzed by qPCR. Results were calculated using the ∆∆Ct method and the expression of passage 6 and passage 8 cells was 
compared to passage 4 for each donor. Results are given as mean + SD of three technical replicates. 
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expression, we predicted potential target genes through 
the use of QIAGEN’s Ingenuity Pathway Analysis 
(IPA®, QIAGEN Redwood City, 
www.qiagen.com/ingenuity). To investigate the overall 
changes that occur during expansion, we divided our 
data into three groups. Expression changes that 
happened in both young and old donor samples were 
analyzed together (Group A c8-c4), and the unique 
expression changes in the old donors (Group B o8-o4) 
and in the young donors (Group C y8-y4) were 
analyzed separately (Fig. 4).  
 
The number of predicted targets for each individual 
miRNA ranged from 14 to 2,359 (see Table S2). A 
 
 
 
Figure 3. Correlation analyses between miRNA expression and expansion time. (A) scatter plot of dct values of 
individual miRNAs at passage 8. (B-F) Correlation of dct at passage 8 with the expansion time (days) was calculated using 
spearman’s correlation. Lower dct corresponds to higher miRNA expression.  
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functional analysis of predicted target genes of 
differentially expressed miRNAs showed  
overrepresentation of cell proliferation and growth, 
cellular assembly and organization and tissue 
development (Table 2, Table S2), all of which are 
related either to the stem cell functions or senescence. 
In addition, some miRNAs belonging to Group A c8-c4 
molecules (such as miR-1225-5p and miR-293-5p) 
putatively regulate genes that are involved in lipid 
metabolism. (Table S2). 
Comparison of predicted miRNA targets with 
differentially expressed mRNA molecules illustrates 
a complex regulatory network of interactions 
 
To narrow down the list of potential targets, we 
compared the predicted targets of all up-regulated or all 
down-regulated miRNAs (Fig. 4A blue circles) with the 
mRNA expression data derived from the same cells 
(Fig. 4A red circles). The overlap between these two 
groups was then investigated in each group (A-C). In 
 
 
 
Figure 4. Target prediction analysis of miRNA. (A) Predicted targets for differentially expressed miRNAs were compared to 
the differentially expressed mRNAs in the same cells. (B) The number of putative miRNA-mRNA interactions and the number of 
individual miRNAs or mRNAs that account for those interactions. 
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group A (c8-c4), the number of down-regulated mRNAs 
was 13, 7 of which, were predicted to be potential 
targets of up-regulated miRNAs in the same group. On 
the other hand, 23 mRNAs were up-regulated, and, we 
demonstrate in more detail the number of predicted 
interactions and the number of miRNA and mRNA 
molecules participating in these interactions in Figure 
4B. 
 
Based on the known functions of miRNAs, we focused 
on the mRNAs that were down-regulated and 
corresponding miRNAs that were up-regulated and the 
mRNAs that were up-regulated and corresponding 
miRNAs that were down-regulated in group A. Seven 
potential genes were down-regulated (FAM46B, 
HMGB2, HNRNPH1, 4 of them were predicted to be 
potential targets of down-regulated miRNAs, while 8 
were potential targets of up-regulated miRNAs (Fig. 
4A). In group B (o8-o4), 374 mRNAs were down-
regulated. Of these, 70 were predicted to be potential 
targets of up-regulated miRNAs, while 137 were 
potential targets of down-regulated miRNAs in the 
same group. On the other hand, 197 mRNAs were up-
regulated, with 113 predicted to be potential targets of 
down-regulated miRNAs while 65 were potential 
targets of down-regulated miRNAs. Lastly, in group C, 
down-regulation was only seen in 44 mRNAs, 8 of 
which were predicted as potential targets of up-
regulated miRNAs and 18 were predicted targets of 
down-regulated miRNAs. In contrast, 130 mRNAs were 
up-regulated. Of these, 57 were predicted to be potential 
targets of down-regulated miRNAs, while 42 were 
potential targets of up-regulated miRNAs. Since a 
single miRNA may target several mRNA molecules and 
an individual mRNA molecule may be regulated by 
several different miRNA molecules LBR, OLFML3, 
RMI1, SOCS3) and four potential genes were up-
regulated (BHLHE4, CCND1, CMTM4, CYLD). In 
addition to the miRNAs whose expression changed in 
both groups during expansion, these genes are potential 
targets of several other miRNAs only found in unique 
groups B and C, which further supports the finding (Fig. 
5, Table S3).  
 
DISCUSSION 
 
We previously reported interesting changes in 
membrane lipid composition and gene expression 
Table 2. Functional classification of miRNA targets. 
miRNA  Molecular and Cellular function p-value number of molecules 
Group A c8-c4    
miR-3665 ↑ Cellular Assembly and Organization 9.65E-09-4.21E-02 124/892 
miR-17-5p ↓ Cell Cycle 1.05E-07-6.68E-03 175/1419 
miR-15-5p ↓ Cellular Growth and Proliferation 1.97E-08-7.08E-03 369/1419 
miR-92a-3p ↓ Cellular Assembly and Organization 6.53E-08-2.72E-02 202/1140 
miR-92a-3p ↓ Tissue Development 6.87E-07-2.67E-02 179/1140 
GroupB o8-o4    
miR-181a-5p ↑ Cellular Growth and Proliferation 1.89E-08-8.62E-03 399/1498 
miR-23a-3p ↑ Tissue Development 7.15E-10-1.9E-02 157/1506 
miR-16-5p ↓ Cellular Assembly and Organization 1.75E-08-5.65E-03 271/2020 
miR-19a-3p ↓ Cellular Assembly and Organization 7.8E-07-1.43E-02 195/1450 
miR-19a-3p ↓ Cellular Growth and Proliferation 2.77E-07-1.15E-02 382/1450 
miR-218-5p ↓ Tissue Development 5.15E-07-2.11E-02 143/1279 
miR-503-5p ↓ Cell Cycle 2.49E-11-7.8E-03 106/772 
Group C y8-y4    
miR-3180-3p ↑ Cellular Assembly and Organization 2.55E-07-2.48E-02 154/1102 
miR-3180-3p ↑ Tissue Development 3.04E-08-2.48E-02 124/1102 
miR-130a-3p ↓ Cellular Assembly and Organization 5.44E-07-3.73E-03 179/1253 
miR-130a-3p ↓ Cellular Growth and Proliferation 9.96E-08-3.68E-03 335/1253 
miR-155-5p ↓ Tissue Development 8.23E-07-3.91E-03 216/1253 
miR-155-5p ↓ Cell Cycle 1.97E-07-1.12E-02 94/799 
Categories with p-value<E-06 are shown in the table. See Table S2 for the complete list of miRNAs. 
Arrows indicate up- or down regulation. Number of predicted target genes found in the category/ total 
number of predicted targets are shown in the number of molecules column. 
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during long-term expansion of BM-MSCs [13]. Using 
the same biological material, we studied more 
thoroughly changes in both mRNA and miRNA 
expression and their interactions. The primary aim of 
the study was to find senescence-related miRNA 
signatures. For this purpose, our study material was 
optimal: there was a clear age difference between the 
young donors (average age 22.3) and the old donors 
(average age 76). In previous miRNA studies where the 
importance of the age of the donor has been studied in 
MSCs, the age difference has not been as pronounced 
[15, 16]. Despite the clear age difference, miRNA 
expression was similar in both age groups in the early 
passage cells (p4). We further investigated whether 
miRNA and mRNA expression responds differently to 
expansion in old and young donor BM-MSCs. 
Previously described miRNA signatures were observed 
in all the BM-MSCs studied, with expression remaining 
unchanged during expansion. The expression of many 
other miRNAs was altered during expansion albeit only 
moderately. Interestingly, the majority of the 
differentially expressed miRNAs were unique for either 
old or young donors, and they regulated different 
pathways (Fig. 6). Only some of them underwent 
similar changes in both groups, indicating that 
expansion influences different processes in BM-MSCs 
from young and old donors. In our analysis, we mainly 
concentrated on those miRNAs that were either up- or 
down-regulated in both groups and compared their 
predicted targets with our previous mRNA results. This 
enabled us to find needles in the haystack and narrow 
down the analyzed miRNAs and their potential mRNA 
targets. 
 
We successfully validated microarray results with qPCR 
using selected miRNAs. Interestingly, when all BM-
MSCs at passage 8 were analyzed and the expression 
levels of miRNAs compared with the proliferation data, 
we found a correlation between dct values and 
expansion time. Functions of miR-762, miR-1207, miR-
1915 miR-3665 and miR-4281 are still largely 
unknown, but some of them are involved in 
immunological processes. MiR-762 and miR-1207 are 
highly expressed in human corneal epithelial cells, 
where they have been suggested to regulate genes of the 
innate immune system and contribute to defense against 
pathogens [19]. When the miRNA expression of 
different types of T-cells was analyzed, miR-4281 was 
identified as one potential marker for regulatory T-cells, 
which play a major role in the suppression of an 
overheated immune response [20]. 
 
The detailed examination of the miRNA results 
revealed high expression of miRNA members of miR- 
17/92 cluster and its two paralogues miR-106b/25 and 
miR-106a/363. The expression of several miRNAs from 
the miR-17/92 cluster, including miR-17, miR-18a, 
miR-19a, and miR-20a, was decreased in the old 
donors’ cells whereas the expression of miR-93, miR-25 
and miR- 92a-3p was decreased in the young donors’ 
 
 
 
Figure 5. Expansion-induced miRNA-mRNA interactions. Interactions of adverse expression changes are shown in the 
figure. Green color of the miRNA or mRNA represents up-regulation and red color represents down-regulation. Gray arrows 
indicate interactions in the group A c-8-c4 whereas red color represents the old donors group (Group B o8-o4) and the blue color 
represents the young donors group (Group C y8-y4). See also Table S3. 
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cells. The miR-17/92 cluster is one of the most 
extensively studied microRNA clusters. Previous 
studies have shown down-regulation of miR-17, miR-
20a and miR-106a in aging [21]. Direct targeting of 
p21, one of the key regulators of cell cycle, leads to the 
attenuation of proliferation and senescence in human 
fibroblasts [22].We have previously shown that the 
protein expression of p21 increases during MSC 
expansion towards senescence. This indicates that at 
least in the old donors’ group, the expansion of BM-
MSCs leads to a decrease in the expression of several 
members of the miR17/92 cluster, which may in turn 
increase p21 expression, finally resulting in cell cycle 
arrest.  
 
Figure 6. Pathway analyses of miRNA mRNA interactions. Canonical pathways were analyzed through the use of QIAGEN’s 
Ingenuity Pathway Analysis. (A) Group B o8-o4 down-regulated target mRNAs for up-regulated miRNAs (B) Group B o8-o4 up-
regulated target mRNAs for down-regulated miRNAs (C). Group C y8-y4 down-regulated target mRNAs for up-regulated miRNAs 
(D). Group C y8-y4 up-regulated target mRNAs for up-regulated miRNAs. 
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One of the first identified targets of miR-17/92 cluster is 
the phosphatase and tensin homolog (PTEN). Although 
PTEN is not up-regulated in our data, the functional 
analysis of up-regulated mRNA targets of down-
regulated miRNAs reveals enrichment of PTEN 
signaling and cell cycle related pathways (Fig. 6D). In 
recent years, several targets for miR17/19 have been 
experimentally validated. Our results demonstrate that 
several such genes are up-regulated in BM-MSCs while 
the corresponding miRNA is down-regulated (Table 
S4). However, some of the potential targets were also 
down-regulated in BM-MSCs. This may be a result of 
autoregulation when miRNA expression is regulated by 
a transcription factor that is known to be a potential 
target. For instance, transcription factors E2F1-3 have 
been shown to directly regulate the expression of miR-
20a while miR-20a simultaneously regulates the 
translation of E2Fs [23, 24]. 
 
Even though we demonstrated that expansion effects in 
the old and young donors’ BM-MSCs were different, 
we were able to identify a set of potentially miRNA 
regulated genes whose expression changed in both 
young and old donors’ BM-MSCs (Fig. 5, Table S3). 
BHLHE41, CCND1, CMTM4, and CYLD were all up-
regulated whereas FAM46B, HMGB2, HNRNPH1, LBR, 
OLFML3, RMI1, and SOCS3 were down-regulated. 
Notably, some of these genes were targets of one 
common miRNA molecule whereas other mRNAs 
interact with several miRNA molecules. In addition to 
the common miRNA molecules, these genes are targets 
for unique miRNAs whose expression is changed in 
either young or old donors’ BM-MSCs (Fig. 5). 
BHLHE41 (DEC2) is involved in the control of 
circadian rhythm, apoptosis, cell differentiation and 
inflammation [25]. Cyclin D1 (CCND1) controls cell 
cycle progression while increased senescence is 
reported to be associated with increased 
CCND1expression levels [26]. Similarly, CMTM4 has 
also been shown to inhibit cellular growth [27]. CYLD 
has been proposed to be a master regulator of 
inflammation and apoptosis [28], further supporting the 
link between proliferation and immunomodulatory 
changes. 
 
Biological functions of down-regulated genes, on the 
other hand, are not well-known. For instance, FAM46B 
was only recently described as active non-canonical 
poly(A) polymerase and it has been connected to cell 
cycle regulation based on sequence homology [29]. 
Since the functions and expression levels of this gene in 
different cells are not yet known, it remains for future 
studies to find out the importance of this gene in BM-
MSCs. 
 
One of the major biological roles of MSCs stems from 
their capacity to modulate many immunological 
processes. Specifically, MSCs suppress T-cell 
proliferation via indoleamine 2,3-dioxygenase (IDO) 
[30] and prostaglandin E2 (PGE2), and they also work 
together with T-cells in inflammation via purinergic 
signaling [31]. MiR-21, miR-155 and miRNA family 
17/92 are called immunomirs and they regulate T-cell 
differentiation, function and aging [7]. Of these 
miRNAs, miR-21 is highly expressed in MSCs and its 
expression has been shown to be induced by an anti-
inflammatory lipid molecule, resolvin D1, which 
participates in the attenuation of the inflammatory 
response [32]. MiR-155, on the other hand, inhibits the 
immunosuppressive capacity of MSCs in mice by 
reducing iNOS expression [33]. MiR-181 is not 
included in immunomirs, but it has been shown to be 
involved in T- and B-cell development [34]. In MSCs, 
elevated miR-181 expression enhances IL6 and IDO 
expression, and the capability of MSCs to suppress 
mitogen activated T-cell proliferation was also 
attenuated by miR-181 in, at least partly, IL6-dependent 
manner [35].  
 
In our study, we found several miRNAs (miR-181,- 
718,- 874, -762, -2861) with SOCS3 as a predicted 
target up-regulated in our study, indicating that this 
major regulator of inflammation is strongly regulated in 
MSCs during expansion. Supporting evidence comes 
from down-regulation of SOCS3 mRNA expression 
during expansion and from old donor MSCs where 
feedback regulator cytokine IL-6 was also up-regulated 
during expansion. The role of JAK-STAT signaling and 
SOCS3 is well established not only in regulation of 
macrophage polarization (M1/M2), but also in Th17 
differentiation [36, 37]. The function of SOCS3 in 
MSCs has not yet been described, but our current 
observations combined with our previous results 
showing lowering of immunosuppressive effect during 
expansion suggest an interesting link between 
expansion and immunomodulation. Chromatin protein 
HMGB2 has a crucial role in maintaining stem cell 
pluripotency [38] and it has been shown to regulate 
differentiation of MSCs [39]. HMGB1, a HMGB2 
isoform, is recognized as an inflammatory cytokine [40] 
and recently HMGB2’s role in inflammation was also 
reported at least in neuroinflammation [41].  
 
As a summary, we investigated expansion-induced 
changes in miRNA expression in BM-MSCs collected 
from donors of different ages and we could confirm 
moderate changes in miRNA and mRNA expression 
that pointed towards interplay between cell cycle, 
senescence and immunomodulation. As one of the key 
players in the regulation of the immune system, SOCS3 
was targeted by several miRNAs and affected by 
expansion. Expression of both previously described and 
functionally unknown miRNAs was changed, a finding 
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which was further supported by the mRNA results. In 
addition to studies with short term experiments on 
miRNA/ target gene –changes we still need miRNA 
profile data to broaden our understanding of the 
complexity of holistic changes in long lasting processes. 
 
MATERIALS AND METHODS 
 
Isolation and cell culture of BM-MSCs 
 
hBM-MSCs were obtained from bone marrow aspirates 
taken from the iliac crest or upper femur metaphysis of 
adult patients after written informed consent. All patient 
protocols were approved by the Ethical Committee of 
Northern Ostrobothnia Hospital District or Ethical 
Committee of Hospital District of Helsinki and 
Uusimaa. The hBM-MSCs were isolated and 
characterized as previously described [13]. Cells were 
cultured in minimum essential alpha-medium (αMEM) 
supplemented with 20mM HEPES, 10% heat 
inactivated fetal bovine serum (FBS), 2mM L-
glutamine and 100 units/mL penicillin and 100 μg/mL 
streptomycin (all from Gibco, Invitrogen, Paisley, UK). 
The same serum lot was used throughout the study. The 
cells were plated at a density of 1000 cells/cm2, medium 
was renewed twice a week and the cells were harvested 
when 70-80% confluent.  
 
RNA isolation 
 
RNA was extracted using Qiagen AllPrep DNA/RNA 
Mini Kit (Cat. no. 80204, Qiagen, CA, USA) and a 
Qiagen supplementary protocol “Purification of total 
RNA containing miRNA from animal cells using the 
RNeasy Plus Mini Kit (cat. no. 74134). In brief, the 
Qiagen AllPrep DNA/RNA Mini kit was first used to 
lyse the cells and homogenize the lysate. The DNA was 
then bound to the AllPrep DNA spin column following 
the vendor’s instructions. The flow-through, after DNA 
binding, was used to isolate RNA (containing miRNA) 
using the Qiagen supplementary protocol and the 
Qiagen RNeasy Plus Mini Kit mentioned above. The 
quality of RNA was controlled by BioAnalyzer Small 
RNA method. 
 
MicroRNA expression profiling  
 
Labeled RNAs (800 ng/sample) were hybridized onto 
an Agilent Human miRNA 8x60K microarray (release 
16.0) and then the slides were washed and scanned 
according to the manufacturer’s recommendations. The 
raw data files (.txt files) were imported into the R v. 
2.13 software [42] and preprocessed by the 
BioConductor package limma v.3.4.5[43]. After quality 
control of the data, the median probe intensities were 
log2 transformed and normalized according to the 
method of the quantiles [44]. The probes for the same 
Entrez Genes or lincRNAs (as of 1st January 2012) 
were averaged. 
 
A linear model including the AGE*PASSAGE + 
SUBJECT + DYE terms followed by a moderated t-test 
was utilized for finding the differentially expressed 
genes in the comparisons of interest (nominal p-value < 
0.01).  
 
Quantitative PCR  
 
For miRNA analyzes, 100 ng total RNA were reverse-
transcribed and amplified with real-time PCR using 
miScript-System including miScript II RT-Kit, miScript 
SYBR-Green PCR-Kit and miScript Primer Assay 
(Qiagen) according to the manufacturer's protocol. For 
endogenous control, RNU6 was used. All PCR 
reactions were performed in triplicate in 384-well plates 
and measured by ABI 7900HT detection system Mean 
values and standard deviations were calculated and fold 
changes were determined using the ΔΔCT method. 
 
Target prediction and pathway analysis 
 
Prediction and functional analysis of putative targets for 
selected miRNAs was performed through the use of 
QIAGEN’s Ingenuity Pathway Analysis (IPA QIAGEN 
Redwood City, www.qiagen.com/ingenuity) 
 
Statistical analysis 
 
Results are represented as mean±standard deviation. 
Pairwise t-test (one tailed) was used to compare the 
groups, and p-value <0.05 was considered statistically 
significant. Non-parametric Spearman correlation was 
used to calculate correlation between miRNA 
expression and proliferation of MSCs. All analyses 
were performed with GraphPad Prism 7.00 software 
(GraphPad Software Inc. La Jolla, CA, USA). 
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